We provide investment banking and M&A advisory to fast growing and established Healthcare Technology companies around the world.
Our Healthcare IT M&A practice is one of our fastest growing teams and supports our client’s transaction goals
Our combined expertise intersects between software, tech-enabled services, and healthcare which provides our clients with a unique set of skills to manage most types of complicated transactions.
Our deal professionals consistently research current healthcare trends, review current transaction multiples, meet with industry leaders, and work with some of the most innovative companies in the industry. Solganick & Co. offers an established team of M&A professionals with a winning track record to provide a comprehensive M&A platform to our clients.
We cover a range of Healthcare IT industry sub-sectors including:
Clinical Decision Support Systems
Compliance and Credentialing
Data Management, Analytics and Artificial Intelligence
Document & Practice Management Software
Electronic Medical Records (EMR)
What to know more?
what our clients have to say
Healthcare IT News and M&A Research
Solganick & Co. has advised Sheridan Capital Partners backed DAS Health in its acquisition of Intentive Healthcare Solutions
DAS Health Ventures, LLC (“DAS Health”), a portfolio company of Sheridan Capital Partners (“Sheridan”), recently announced the acquisition of Itentive, LLC (“Itentive”). Itentive bolsters DAS Health’s ability to improve the healthcare experience by delivering high value health IT and business solutions to physician practices and hospitals. The partnerships expand DAS’s MSP presence and introduce new value-added consulting and support services. DAS Health originally partnered with Sheridan in February 2021 and now serves nearly 2,500 clients and over 25,000 users nationwide.
Solganick & Co. acts as exclusive financial advisor to ITelagen Healthcare in successful sale to DAS Health
Solganick & Co, a leading Investment bank and M&A advisory firm serving the technology and IT services sectors, announced today that it served as the exclusive financial advisor to ITelagen Healthcare in its successful sale to DAS Health, backed by Sheridan Capital Partners.